Methods for treating diabetes with extended release formulations of GLP-1 receptor agonists
The disclosure provides methods for treating diabetes, treating overweight, treating obesity, reducing body weight, treating cardiovascular diseases, treating fatty liver diseases, treating gastrointestinal diseases, and treating neurodegenerative diseases through the once monthly administration of...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | ZIERHUT MATTHEW L CIRINCIONE BRENDA B |
description | The disclosure provides methods for treating diabetes, treating overweight, treating obesity, reducing body weight, treating cardiovascular diseases, treating fatty liver diseases, treating gastrointestinal diseases, and treating neurodegenerative diseases through the once monthly administration of pharmaceutical formulations containing a non-aqueous carrier and GLP-1 receptor agonists that provides therapeutically effective plasma concentration levels of the GLP-1 receptor agonists over the course of a month. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN103906528A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN103906528A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN103906528A3</originalsourceid><addsrcrecordid>eNqNzL0KwjAUxfEsDqK-w_UBCq1F0VGKH4OKg5tDSZuTNlCT0ntFH98IPoDTGf4_zljdz5A2GCYbBpIBWpxvyDhdQcD0ctIS3gJvYGhAB8342sezizR4pmDpcLomWaw1eok3ugnesfBUjazuGLPfTtR8v7sVxwR9KMG9ruEhZXHJ0nyTrpaL9Tb_x3wAZUA7Uw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Methods for treating diabetes with extended release formulations of GLP-1 receptor agonists</title><source>esp@cenet</source><creator>ZIERHUT MATTHEW L ; CIRINCIONE BRENDA B</creator><creatorcontrib>ZIERHUT MATTHEW L ; CIRINCIONE BRENDA B</creatorcontrib><description>The disclosure provides methods for treating diabetes, treating overweight, treating obesity, reducing body weight, treating cardiovascular diseases, treating fatty liver diseases, treating gastrointestinal diseases, and treating neurodegenerative diseases through the once monthly administration of pharmaceutical formulations containing a non-aqueous carrier and GLP-1 receptor agonists that provides therapeutically effective plasma concentration levels of the GLP-1 receptor agonists over the course of a month.</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140702&DB=EPODOC&CC=CN&NR=103906528A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140702&DB=EPODOC&CC=CN&NR=103906528A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZIERHUT MATTHEW L</creatorcontrib><creatorcontrib>CIRINCIONE BRENDA B</creatorcontrib><title>Methods for treating diabetes with extended release formulations of GLP-1 receptor agonists</title><description>The disclosure provides methods for treating diabetes, treating overweight, treating obesity, reducing body weight, treating cardiovascular diseases, treating fatty liver diseases, treating gastrointestinal diseases, and treating neurodegenerative diseases through the once monthly administration of pharmaceutical formulations containing a non-aqueous carrier and GLP-1 receptor agonists that provides therapeutically effective plasma concentration levels of the GLP-1 receptor agonists over the course of a month.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzL0KwjAUxfEsDqK-w_UBCq1F0VGKH4OKg5tDSZuTNlCT0ntFH98IPoDTGf4_zljdz5A2GCYbBpIBWpxvyDhdQcD0ctIS3gJvYGhAB8342sezizR4pmDpcLomWaw1eok3ugnesfBUjazuGLPfTtR8v7sVxwR9KMG9ruEhZXHJ0nyTrpaL9Tb_x3wAZUA7Uw</recordid><startdate>20140702</startdate><enddate>20140702</enddate><creator>ZIERHUT MATTHEW L</creator><creator>CIRINCIONE BRENDA B</creator><scope>EVB</scope></search><sort><creationdate>20140702</creationdate><title>Methods for treating diabetes with extended release formulations of GLP-1 receptor agonists</title><author>ZIERHUT MATTHEW L ; CIRINCIONE BRENDA B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN103906528A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2014</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>ZIERHUT MATTHEW L</creatorcontrib><creatorcontrib>CIRINCIONE BRENDA B</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZIERHUT MATTHEW L</au><au>CIRINCIONE BRENDA B</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Methods for treating diabetes with extended release formulations of GLP-1 receptor agonists</title><date>2014-07-02</date><risdate>2014</risdate><abstract>The disclosure provides methods for treating diabetes, treating overweight, treating obesity, reducing body weight, treating cardiovascular diseases, treating fatty liver diseases, treating gastrointestinal diseases, and treating neurodegenerative diseases through the once monthly administration of pharmaceutical formulations containing a non-aqueous carrier and GLP-1 receptor agonists that provides therapeutically effective plasma concentration levels of the GLP-1 receptor agonists over the course of a month.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | chi ; eng |
recordid | cdi_epo_espacenet_CN103906528A |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | Methods for treating diabetes with extended release formulations of GLP-1 receptor agonists |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T20%3A09%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZIERHUT%20MATTHEW%20L&rft.date=2014-07-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN103906528A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |